• Healthcare Capital & Connections Summit
    September 12 - 14, 2017
    Shanghai, China

    Register Now
  • English | Chinese (中文)

    2016 Summit

    The Healthcare Capital & Connections Summit was founded in 2014 to connect US and Chinese companies and investors. In 2016, attendees also included companies and investors from Canada, Europe and across Asia. The Summit provides opportunities to share cross-border best practices and make connections to facilitate deals.

    1. 2016 Agenda

      DAY ONE:

      TUESDAY, SEPTEMBER 20, 2016

      Pre-Summit Trip to Zhangjiang Pharma Valley Incubator to meet with an early stage pharmaceutical company residing in the incubator.

      O’Melveny & Myers LLP Welcome Reception

      DAY TWO:


      Meeting Agenda 08:00 to 17:00

      Welcome and Opening Remarks

      • Dave Sabow, Silicon Valley Bank
      • Chen Yu, Vivo Capital

      The Emergence of the Innovative Chinese Biotech -

      • Moderator: Judith Li, Lilly Asia Ventures
      • Ji Li, Chief Business Officer, BeiGene
      • Qian Xueming, CEO, MABSPACE Biosciences
      • Hongbo Lu, Managing Director, OrbiMed
      • Guoliang Yu, Executive Chairman and CEO, Crown Bioscience

      Operating Models in China for Foreign Companies -

      • Moderator: Chen Yu, Vivo Capital
      • Jimmy Zhang, Managing Partner, CL Investment Group
      • Alex Xu, CEO, German Medical Technology
      • James Xu, GM, Danaher

      Perspective from Big Pharma -- Keynote:

      • Xianghong Shao, BD & Alliance Director, Pfizer

      Next Frontiers of Global Innovation --

      • Moderator: Fay Xing, Wuxi Ventures
      • Keith Barton, MD, Vision Futures
      • Stefano Buono, CEO, Advanced Accelerator Applications
      • Chris Kaster, Boston Scientific
      • K. Angela MacFarlane, President & CEO, ForSight VISION4, Inc.

      The China Company’s Perspective on In-Licensing Deals --

      • Moderator: Cyber Cao, Vivo Capital
      • ShuJun Yang, Business Development Director, Jichuan Pharma
      • Dr. Xin Huang, Business Development Director, BeiGene
      • Taoxi Lin, Business Development Director, HEC Pharma
      • Peter Ji, Business Development Director, LuoXin Pharma

      Dinner: Sponsored by SPD Silicon Valley Bank

      • Welcome Address: Dave Jones, President of SPD Silicon Valley
      • Bank & Silicon Valley Bank Asia

      HCCS 2016 Main Session

      DAY THREE:

      THURSDAY, SEPTEMBER 22, 2016

      Opening Remarks -- Patrick Brennan, AdvaMed

      China Medtech Local Dynamics: Expanding MNCs in China vs Globalizing Chinese Abroad

      • Helen Chen, Managing Director and Head of China Life Sciences, L.E.K. Consulting

      Hot Trend: Cross Border Deals Are the Rage --

      • Irene Hong, China E-Capital

      Negotiating a Cross Border Deal: Key Considerations --

      • Christina Zhang, Cooley

      The China Overseas Buyer—Strategies and Considerations --

      • Moderator: Andy Clayton, Piper Jaffrey
      • Portia Ku, Partner, O’Melveny & Myers
      • Lefei Sun, Founding Partner, HuaTai Healthcare Investment Fund
      • Jiangfeng Fei, Head of Global Business Development and Strategic
      • Partnership, Sinocar
      • Richard Zhao, General Manager, Strategy and Investment, Fosun
      • Pharma
      • May Li, General Manager of Business Development, Mindray

      Accessing Venture Capital in China --

      • Moderator: Min Cui, Decheng
      • Gavin XU, DT Capital
      • Wei Xu, Founder and Managing Director, Denlux Capital
      • Lynn Yang, Managing Director, Sequoia Capital
      • Bo Liu, Principal, J & J Development Corporation

      How Should Chinese Startups Approach International Markets? --

      • Moderator: Michael Chang, Vivo Capital
      • Jun Bao, CBO, Shenogen
      • Peter Luo, CEO, Adagene
      • Frank Chen, CIO PrinJohnson
      • Rocky Shao, CEO, China Grand

      Will China Become the New Innovation Center in Medtech? --

      • Moderator: Oscar Jazdowski, SPD Silicon Valley Bank
      • Matt Steere, Managing Director, Canaccord
      • Peggy Wang, Founder and Managing Partner, LongTec China Venture
      • Michael Flaschen, VP Transactions, J&J Asia-Pacific Innovation Center
      • Sammy Jiang, VP, Lvye Phama Group
      • Kewen Jin, Managing Partner, Serica Capital / Chairman, The BayHelix Group    

    2. 2016 Investor Attendees

      Investor Attendees

      3E Bioventures Capital
      Abbott Ventures
      Advantech Capital
      AriMed Advisors (Shanghai) Ltd
      AUX Group
      Avalon Ventures
      Baird Capital
      Bosch (China) Investment Ltd
      Boston Scientific Corp, Venture Capital Investing
      Cenova Capital
      CheerLand Investment Group
      China eCapital
      China Renaissance
      CITIC Securities
      Cowin Capital
      Decheng Capital
      Delos Capital
      DT Capital
      Eight Roads Venture China
      Elite Capital (Beijing)
      Fortune Capital
      Fortune Capital
      Fresco Capital
      Frontline Bioventures
      Goldman Sachs
      GP Capital
      Hollyhigh International Capital
      Huatai Healthcare Investment Fund
      Jingze Investment
      Jiuzhitang Co., Ltd
      Johnson & Johnson Development Corporation
      KaiBao Investment
      Kuanping Capital
      Lilly Asia Ventures
      LongTec Hongtao China Ventrues
      Lumira Capital
      LYZZ Capital
      Mandarin Hill Capital
      Marathon Venture Partners
      McKesson Ventures
      Northern Light Venture Capital
      Pfizer Ventures
      Ping An Ventures
      Piper Jaffray & Co.
      Prosperico Ventures
      Qiming Venture Partners
      SAIF Partners
      Sequoia Capital China
      Shanghai Thanksgiving Venture
      Shanghai Zhangjiang Sci-Tech Venture Capital Co. Ltd.
      Shenzhen Miracle Investment Company
      Sofinnova Partners
      Sunshine Asset Management Corporation Limited
      Sunshine Insurance Group
      Vivo Capital
      Wego Group
      West Capital
      Whitesun International
      Wuxi Healthcare Ventures
      YF Capital
      Zhang Jiang Venture
      Zhongping Capital
    • Founders-HCCS-Logos_021617a

      Founding Sponsors

      The Founding Sponsors create a Summit agenda that attracts leading U.S., Chinese and global investors and healthcare companies, resulting in cross-border connections and deals.

      Become a Sponsor

    • OMelveny_Gold-032717a

      Opening Reception Sponsor

      O’Melveny’s wide-ranging legal services encompass litigation, business deals, risk management, regulatory compliance, and government relations.

      Learn More

    • BIO Logo Horizontal 4C Large

      Gold Sponsor

      BIO is the world's largest trade association representing biotechnology companies, academic and R&D centers and related organizations. BIO hosts a portfolio of global investor and partnering events, including the BIO International Convention, world’s largest gathering of the biotechnology industry.

      Learn More

    • GEC-HCCS-logo_040517a

      Gold Sponsor

      CEC Capital Group (formerly China eCapital Corporation) is a leading healthcare sector focused private investment bank. We provide M&A, private placement, and asset management services to clients both in and outside of China, leveraging relationships with 3,000+ institutional investors in China.

      Learn More

    • Cooley_HCCS-Logos_021617a

      Gold Sponsor

      For 20+ years, Cooley has been advising clients from various industries on Greater China-related matters and cross-border transactions in the U.S., China and globally. We represent high-growth and established companies, investors and investment banks with focus on technology and life sciences.

      Learn More

    • DLA-PIPER_GOLD_HCCS-Logos_021617a

      Gold Sponsor

      DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their life sciences and healthcare sector legal needs around the world.

      Learn More

    • Jefferies-Gold-Sponsor_032717a

      Gold Sponsor

      Jefferies, the global investment banking firm, has served companies and investors for over 50 years. The firm provides clients with capital markets and financial advisory services, institutional brokerage and securities research, as well as wealth management.

      Learn More

    • JohnsonJohnson-logo_041017

      Gold Sponsor

      Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better.

      Learn More

  • The presenters at Healthcare Capital & Connections Summit are independent third parties and are not affiliated with SVB Financial Group. See Terms of Use for more detail.

    © 2017 SVB Financial Group. All rights reserved. SVB, SVB FINANCIAL GROUP, SILICON VALLEY BANK, MAKE NEXT HAPPEN NOW and the chevron device are trademarks of SVB Financial Group, used under license. Silicon Valley Bank is a member of the FDIC and the Federal Reserve System. Silicon Valley Bank is the California bank subsidiary of SVB Financial Group (Nasdaq: SIVB).